AZTA
Price
$29.92
Change
-$0.28 (-0.93%)
Updated
Aug 28 closing price
Capitalization
1.37B
81 days until earnings call
FONR
Price
$15.88
Change
+$0.06 (+0.38%)
Updated
Aug 28 closing price
Capitalization
99.98M
Interact to see
Advertisement

AZTA vs FONR

Header iconAZTA vs FONR Comparison
Open Charts AZTA vs FONRBanner chart's image
Azenta
Price$29.92
Change-$0.28 (-0.93%)
Volume$493.95K
Capitalization1.37B
Fonar
Price$15.88
Change+$0.06 (+0.38%)
Volume$7.81K
Capitalization99.98M
AZTA vs FONR Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. FONR commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and FONR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AZTA: $29.92 vs. FONR: $15.88)
Brand notoriety: AZTA and FONR are both not notable
AZTA represents the Pharmaceuticals: Other, while FONR is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 61% vs. FONR: 22%
Market capitalization -- AZTA: $1.37B vs. FONR: $99.98M
AZTA [@Pharmaceuticals: Other] is valued at $1.37B. FONR’s [@Medical Specialties] market capitalization is $99.98M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B. The average market capitalization across the [@Medical Specialties] industry is $10.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileFONR’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • FONR’s FA Score: 0 green, 5 red.
According to our system of comparison, FONR is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 6 TA indicator(s) are bullish while FONR’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 6 bullish, 4 bearish.
  • FONR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than FONR.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +0.27% price change this week, while FONR (@Medical Specialties) price change was +4.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +15.22%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.82%. For the same industry, the average monthly price growth was +6.47%, and the average quarterly price growth was +7.37%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.91% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.82% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.37B) has a higher market cap than FONR($100M). FONR YTD gains are higher at: 4.888 vs. AZTA (-40.160). FONR has higher annual earnings (EBITDA): 23.2M vs. AZTA (11.3M). AZTA has more cash in the bank: 319M vs. FONR (54.4M). FONR has less debt than AZTA: FONR (39.8M) vs AZTA (52.6M). AZTA has higher revenues than FONR: AZTA (669M) vs FONR (103M).
AZTAFONRAZTA / FONR
Capitalization1.37B100M1,372%
EBITDA11.3M23.2M49%
Gain YTD-40.1604.888-822%
P/E RatioN/A12.70-
Revenue669M103M650%
Total Cash319M54.4M586%
Total Debt52.6M39.8M132%
FUNDAMENTALS RATINGS
AZTA vs FONR: Fundamental Ratings
AZTA
FONR
OUTLOOK RATING
1..100
584
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6455
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FONR's Valuation (53) in the Medical Specialties industry is in the same range as AZTA (70) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

FONR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

FONR's SMR Rating (100) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

FONR's Price Growth Rating (55) in the Medical Specialties industry is in the same range as AZTA (64) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

FONR's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTAFONR
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
66%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
50%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
52%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 8 days ago
71%
Bullish Trend 1 day ago
54%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 12 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAUH0.050.01
+12.50%
National American University Holdings, Inc.
BNCDY41.410.21
+0.51%
Banca Mediolanum SPA
QUILF2.20N/A
N/A
Quilter PLC
IDIG0.05N/A
N/A
International Digital Holding, Inc.
MLXEF0.39-0.01
-2.50%
Metals X, Ltd.

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-0.93%
IQV - AZTA
60%
Loosely correlated
-0.04%
RVTY - AZTA
59%
Loosely correlated
+0.72%
A - AZTA
59%
Loosely correlated
+5.28%
MTD - AZTA
59%
Loosely correlated
-0.17%
BRKR - AZTA
58%
Loosely correlated
-0.39%
More

FONR and

Correlation & Price change

A.I.dvisor tells us that FONR and AZTA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FONR and AZTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FONR
1D Price
Change %
FONR100%
+0.38%
AZTA - FONR
32%
Poorly correlated
-0.93%
IMDX - FONR
30%
Poorly correlated
+1.21%
AVHHL - FONR
30%
Poorly correlated
N/A
KIDS - FONR
27%
Poorly correlated
-0.88%
VREX - FONR
26%
Poorly correlated
+0.17%
More